United-Guardian Inc
UG7.000USD
-0.070-0.99%
Cierre 11/05, 16:00（ET）Cotizaciones retrasadas 15 min
32.16MCap. mercado
12.58P/E TTM
Más Datos de United-Guardian Inc Compañía
United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.
Información de United-Guardian Inc
Símbolo de cotizaciónUG
Nombre de la empresaUnited-Guardian Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivo- -
Número de empleados24
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección230 Marcus Blvd
CiudadHAUPPAUGE
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal11788
Teléfono16312730900
Sitio Webhttps://u-g.com/
Símbolo de cotizaciónUG
Fecha de salida a bolsaMar 17, 1980
Director ejecutivo- -
Ejecutivos de United-Guardian Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth H. (Ken) Globus
Mr. Kenneth H. (Ken) Globus
Chairman of the Board
Chairman of the Board
1.32M
--
Mr. Arthur M. Dresner
Mr. Arthur M. Dresner
Independent Director
Independent Director
12.18K
--
Mr. Lawrence F. Maietta, CPA
Mr. Lawrence F. Maietta, CPA
Independent Director
Independent Director
4.00K
--
Ms. Donna Vigilante
Ms. Donna Vigilante
President, Director
President, Director
2.00
--
Mr. Peter A. Hiltunen
Mr. Peter A. Hiltunen
Senior Vice President, Production and Procurement
Senior Vice President, Production and Procurement
--
--
Ms. Andrea J. Young
Ms. Andrea J. Young
Principal Financial Officer, Controller, Treasurer and Secretary
Principal Financial Officer, Controller, Treasurer and Secretary
--
--
Mr. S. Ari Papoulias
Mr. S. Ari Papoulias
Independent Director
Independent Director
--
--
Mr. Andrew A. Boccone
Mr. Andrew A. Boccone
Independent Director
Independent Director
--
--
Ms. Catherine Joy Kolinski
Ms. Catherine Joy Kolinski
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kenneth H. (Ken) Globus
Mr. Kenneth H. (Ken) Globus
Chairman of the Board
Chairman of the Board
1.32M
--
Mr. Arthur M. Dresner
Mr. Arthur M. Dresner
Independent Director
Independent Director
12.18K
--
Mr. Lawrence F. Maietta, CPA
Mr. Lawrence F. Maietta, CPA
Independent Director
Independent Director
4.00K
--
Ms. Donna Vigilante
Ms. Donna Vigilante
President, Director
President, Director
2.00
--
Mr. Peter A. Hiltunen
Mr. Peter A. Hiltunen
Senior Vice President, Production and Procurement
Senior Vice President, Production and Procurement
--
--
Ms. Andrea J. Young
Ms. Andrea J. Young
Principal Financial Officer, Controller, Treasurer and Secretary
Principal Financial Officer, Controller, Treasurer and Secretary
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical
1.45M
51.15%
Cosmetic Ingredients
896.55K
31.59%
Medical
490.00K
17.26%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.35M
82.68%
Other Countries
491.70K
17.32%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmaceutical
1.45M
51.15%
Cosmetic Ingredients
896.55K
31.59%
Medical
490.00K
17.26%
Estadísticas de accionistas
Actualizado: jue., 15 de may
Actualizado: jue., 15 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Globus (Kenneth H)
28.69%
Parker (Betsee)
6.76%
Gabelli Funds, LLC
4.30%
Renaissance Technologies LLC
4.09%
The Vanguard Group, Inc.
3.27%
Otro
52.89%
Accionistas
Accionistas
Proporción
Globus (Kenneth H)
28.69%
Parker (Betsee)
6.76%
Gabelli Funds, LLC
4.30%
Renaissance Technologies LLC
4.09%
The Vanguard Group, Inc.
3.27%
Otro
52.89%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
35.81%
Investment Advisor
10.92%
Investment Advisor/Hedge Fund
7.49%
Hedge Fund
4.43%
Research Firm
0.04%
Otro
41.30%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
51
1.05M
22.89%
-45.25K
2025Q2
57
2.69M
58.59%
-64.03K
2025Q1
57
2.68M
58.39%
-120.69K
2024Q4
60
2.71M
58.96%
-64.04K
2024Q3
59
2.71M
59.08%
-126.33K
2024Q2
58
2.75M
59.88%
-147.10K
2024Q1
57
2.75M
59.79%
-84.33K
2023Q4
58
2.74M
59.67%
-102.44K
2023Q3
55
2.73M
59.32%
-72.02K
2023Q2
55
2.69M
58.54%
-161.09K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Globus (Kenneth H)
1.32M
28.69%
--
--
Mar 31, 2025
Parker (Betsee)
310.59K
6.76%
-26.54K
-7.87%
Mar 31, 2025
Gabelli Funds, LLC
197.50K
4.3%
+2.00K
+1.02%
Jun 30, 2025
Renaissance Technologies LLC
187.96K
4.09%
-1.00K
-0.53%
Jun 30, 2025
The Vanguard Group, Inc.
150.40K
3.27%
--
--
Jun 30, 2025
Monongahela Capital Management
89.77K
1.95%
-3.86K
-4.12%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
76.93K
1.67%
+50.00
+0.07%
Jun 30, 2025
Teton Advisors, Inc.
53.96K
1.17%
-200.00
-0.37%
Jun 30, 2025
Parthenon LLC
51.91K
1.13%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
32.60K
0.71%
-244.00
-0.74%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
Dimensional US Core Equity 1 ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dividendos
Un total de
15.11M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 30, 2025
UG.NB Final Cash Dividend of gross USD 0.35 paid on Feb 18, 2025 going ex on Feb 10, 2025
Feb 10, 2025
Feb 18, 2025
Feb 10, 2025
Jul 12, 2024
UG.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 31, 2024 going ex on Jul 23, 2024
Jul 23, 2024
Jul 31, 2024
Jul 23, 2024
Feb 02, 2024
UG.NB Final Cash Dividend of gross USD 0.25 paid on Feb 20, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 20, 2024
Feb 09, 2024
Jul 14, 2023
UG.NB Interim Cash Dividend of gross USD 0.1 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Nov 21, 2022
UG.NB Final Cash Dividend of gross USD 0.31 paid on Dec 07, 2022 going ex on Nov 25, 2022
Nov 28, 2022
Dec 07, 2022
Nov 25, 2022
May 12, 2022
UG.NB Interim Cash Dividend of gross USD 0.37 paid on Jun 01, 2022 going ex on May 20, 2022
May 23, 2022
Jun 01, 2022
May 20, 2022
Nov 18, 2021
UG.NB Final Cash Dividend of gross USD 0.65 paid on Dec 07, 2021 going ex on Nov 26, 2021
Nov 29, 2021
Dec 07, 2021
Nov 26, 2021
May 20, 2021
UG.NB Interim Cash Dividend of gross USD 0.48 paid on Jun 07, 2021 going ex on May 27, 2021
May 31, 2021
Jun 07, 2021
May 27, 2021
Nov 20, 2020
UG.NB Final Cash Dividend of gross USD 0.36 paid on Dec 08, 2020 going ex on Nov 30, 2020
Dec 01, 2020
Dec 08, 2020
Nov 30, 2020
May 21, 2020
UG.NB Interim Cash Dividend of gross USD 0.42 paid on Jun 17, 2020 going ex on Jun 02, 2020
Jun 03, 2020
Jun 17, 2020
Jun 02, 2020
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
